von Tobias Borgers | Juli 15, 2021 | Glaxo
New drug approvals are the holy grail for pharmas big and small, but a slate of regulatory nods doesn’t automatically translate to top performance. In the last five years, the world’s top 11 drugmakers have brought 76 new meds to market, Evaluate Vantage said...
von Tobias Borgers | Juli 15, 2021 | Frewitt
Life sciences investor Novo Holdings will acquire early drug development services platform provider, Altasciences, both groups have announced. Altasciences has grown in the past decade and now operates across six facilities in the US and Canada, employing over 1,300...
von Tobias Borgers | Juli 10, 2021 | Bayer
Über BayerBayer ist ein weltweit tätiges Unternehmen mit Kernkompetenzen auf den Life-Science-Gebieten Gesundheit und Ernährung. Mit seinen Produkten und Dienstleistungen will das Unternehmen Menschen nützen und die Umwelt schonen, indem es zur Lösung grundlegender...
von Tobias Borgers | Juli 9, 2021 | IMA
IMA Coffee high-speed aluminium capsule filler serves Coind’s sustainable needs With a more than consolidated partnership lasting 50 years, IMA and Coind fully embody the meeting of two top representatives in the Emilian Food and Packaging Valley. Both founded in...
von Tobias Borgers | Juli 7, 2021 | Bayer
Clean Science and Technology’s ₹1,546 crore IPO has opened for subscription and investors can apply till July 9. The IPO has a price band of ₹880-900 per share. The IPO is a complete offer for sale (OFS) by existing promoters and other shareholders to reduce their...
